Concerto HealthAI and Pfizer to Develop New Study Designs Using Real-world Evidence and AI for Various Cancers
Concerto HealthAI (MA, USA) and Pfizer (NY, USA) have announced the expansion of their existing collaboration, with the aim of developing new study designs for various cancers by employing real-world evidence and artificial intelligence (AI).
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.